German sickness costs hit a record €85 bn; Labour Minister Bärbel Bas sidesteps the data while Volkswagen’s board fractures into opposing camps
Executive summary: New data show German companies’ sickness‑related costs reached €85 bn, a record level. Labour Minister Bärbel Bas has not responded to the figures, while Volkswagen’s board is divided on strategy amid employee fears of job losses and plant shutdowns. The cost surge pressures public finances and corporate balance sheets, and the minister’s silence delays potential reforms to the sickness‑benefit system. VW’s internal split signals possible restructuring that could affect 600,000+ jobs and Germany’s automotive output.
Who is involved: Bärbel Bas (Federal Minister of Labour and Social Affairs), Volkswagen AG supervisory board and works council, German employers’ associations, Bundestag health‑policy committees.
Likely next: A supervisory board meeting this week may clarify VW’s restructuring plan; a parliamentary hearing on sickness‑cost reform is expected in September 2026; labour‑union negotiations with VW are scheduled for early October.
The Handelsblatt Morning Briefing podcast reports that employer‑paid sick‑leave costs in Germany have risen to a historic €85 billion, yet Labour Minister Bärbel Bas has not publicly engaged with the new figure, leaving the policy debate stalled. The surge reflects higher absenteeism across industries and adds to the fiscal burden on firms already facing weak demand and rising energy prices. Without a clear governmental response, companies may resort to stricter attendance controls or seek temporary relief measures, which could affect labour relations and productivity. At the same time, Volkswagen’s supervisory board is divided into two camps over impending plant‑closure and workforce‑reduction plans. The split mirrors the wider uncertainty in Germany’s manufacturing base, where firms are weighing cost‑cutting against the risk of losing skilled labour. Until a consensus emerges, VW is likely to delay final decisions on site rationalisation, prolonging uncertainty for suppliers and regional economies that depend on the automaker’s output. In the near term, the combination of record sick‑leave expenses and corporate indecision at VW puts pressure on policymakers to clarify sick‑leave financing rules and to facilitate dialogue between management and unions. How quickly Berlin and corporate leaders address these intertwined challenges will shape the short‑term trajectory of Germany’s industrial sector.
Timeline
- — Morning Briefing Podcast: Bärbel Bas ignoriert das 85-Milliarden-Problem der Wirtschaft / VW: Vorstand zerfällt in zwei Lager (Handelsblatt)
- — Morning Briefing: Bärbel Bas ignoriert das 85-Milliarden-Problem der Wirtschaft (Handelsblatt)
- — Reformen: „Ich bin koalitionstreu, aber …“ – Bärbel Bas verärgert mit Ansage zur Attestpflicht die Union (Handelsblatt)
Analysis — what this means
Likely next events
- Volkswagen supervisory board meeting (week of 31 Aug 2026) – decision on plant‑closure roadmap
- Bundestag committee hearing on sickness‑cost reform (mid‑September 2026)
- IG Metall‑VW collective‑bargaining talks (early October 2026)
Sectors affected
- Automotive manufacturing (Volkswagen, suppliers)
- Health‑insurance and sickness‑benefit administration
- Public‑sector budgeting
Regulatory implications
- Possible amendment to the Entgeltfortzahlungsgesetz to cap employer‑paid sick leave
- Increased oversight by the Federal Ministry of Labour and Social Affairs on sickness‑cost reporting
Historical parallels
- 2023 German sickness‑cost spike prompted a temporary Krankengeld reform
- 2019 Volkswagen emissions scandal led to a board split and major restructuring
Key entities
Sources
Open the full interactive case file on Beyond →